Enanta Pharmaceuticals
ENTA
#8067
Rank
S$0.46 B
Marketcap
S$16.15
Share price
-3.08%
Change (1 day)
76.27%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Net assets

Net assets on the balance sheet as of March 2026 : S$0.14 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company has S$0.14 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Enanta Pharmaceuticals - Net assets on balance sheet (from 2011 to 2026)

Net assets by year

Year Net assets Change
2025-09-30$S$83.49 M-49.56%
2024-09-30$S$0.16 B-44.09%
2023-09-30$S$0.29 B-35.81%
2022-09-30$S$0.46 B-14.98%
2021-09-30$S$0.54 B-12.74%
2020-09-30$S$0.62 B-2.74%
2019-09-30$S$0.63 B18.76%
2018-09-30$S$0.53 B31.28%
2017-09-30$S$0.41 B11.33%
2016-09-30$S$0.36 B9.55%
2015-09-30$S$0.33 B77.24%
2014-09-30$S$0.18 B36.79%
2013-09-30$S$0.13 B156.83%
2012-09-30$S$53.98 M89.33%
2011-09-30$S$28.51 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
S$104.03 B 69,535.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$49.88 B 33,288.80%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
-S$8.48 Billion-5,771.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$24.81 B 16,507.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$58.86 B 39,296.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$25.76 B 17,142.06%๐Ÿ‡บ๐Ÿ‡ธ USA